Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listSC-43

SC-43

  • CAS NO.:1400989-25-4
  • Empirical Formula: C21H13ClF3N3O2
  • Molecular Weight: 431.8
  • MDL number: MFCD31380911
  • Update Date: 2024-11-19 20:33:22
SC-43 Structural

What is SC-43?

Biological Activity

SC-43 is a derivative of sorafenib, an agonist of Src-homology protein tyrosine phosphatase-1 (SHP-1/PTPN6), which reduces liver fibrosis. SC-43 can reduce p-STAT3 and induce apoptosis, and has antitumor activity.

in vitro

SC-43 (0-10 μM; 24-72 hours; HuCCT-1, KKU-100, and CGCCA cells) treatment reveals the anti-proliferative effects in cholangiocarcinoma (CCA) cell lines in a dose-dependent manner after treating 24, 48 and 72 hours respectively.  
Its treatment shows increased sub-G1 cells and G2-M arrest, indicating SC-43 induced differential apoptotic effects in these cell lines.  
Its (0-10 μM; 24 hours; HuCCT-1, KKU-100, and CGCCA cells) treatment demonstrates significant increase in cleaved caspase-3 and PARP level.  
Its activates SH2 domain-containing phosphatase 1 (SHP-1) activity, leading to p-STAT3 and downstream cyclin B1 and Cdc2 downregulation. Its augments SHP-1 activity by direct binding to N-SH2 and relief of its autoinhibition.

Cell Cycle Analysis

Cell Line: HuCCT-1, KKU-100, and CGCCA cells
Concentration: 0 μM, 1 μM, 2.5 μM, 5 μM, 10 μM
Incubation Time: 24 hours
Result: Showed increased sub-G1 cells and G2-M arrest.

Western Blot Analysis

Cell Line: HuCCT-1, KKU-100, and CGCCA cells
Concentration: 0 μM, 1 μM, 2.5 μM, 5 μM, 10 μM
Incubation Time: 24 hours
Result: Demonstrated significant increase in cleaved caspase-3 and PARP level.

in vivo

SC-43 (10-30 mg/kg; oral gavage; daily; for 23 days; male NCr athymic nude mice) treatment exhibits xenograft tumor growth inhibition, p-STAT3 reduction and SHP-1 activity elevation.

Animal Model: Male NCr athymic nude mice (5-7 weeks of age) injected with HuCCT-1 cells
Dosage: 10 mg/kg or 30 mg/kg
Administration: Oral gavage; daily; for 23 days
Result: Exhibited xenograft tumor growth inhibition, p-STAT3 reduction and SHP-1 activity elevation.

Properties of SC-43

Boiling point: 462.0±45.0 °C(Predicted)
Density  1.46±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
solubility  DMSO: 250 mg/mL (578.97 mM)
form  A solid
pka 12.92±0.70(Predicted)
color  White to off-white

Safety information for SC-43

Computed Descriptors for SC-43

Related products of tetrahydrofuran

You may like

  • Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate 99%
    Dimethyl [2-oxo-3-[3-(trifluoromethyl)phenoxy]propyl]phosphonate 99%
    54094-19-8
    View Details
  • 85-81-4 99%
    85-81-4 99%
    85-81-4
    View Details
  • Cyclopentane carboxxylic acid 3400-45-1 99%
    Cyclopentane carboxxylic acid 3400-45-1 99%
    3400-45-1
    View Details
  • 208111-98-2 (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten- 1-yl]-2H-cyclopenta[b]furan-2-one 99%
    208111-98-2 (3aR,4R,5R,6aS)-5-(Benzoyloxy)hexahydro-4-[(1E)-3-oxo-4-[3-(trifluoromethyl)phenoxy]-1-buten- 1-yl]-2H-cyclopenta[b]furan-2-one 99%
    208111-98-2
    View Details
  • 2033-24-1 99%
    2033-24-1 99%
    2033-24-1
    View Details
  • Meldrums acid 2033-24-1 99%
    Meldrums acid 2033-24-1 99%
    2033-24-1
    View Details
  • Cyaclopentane carboxylic acid 99%
    Cyaclopentane carboxylic acid 99%
    3400-45-1
    View Details
  • 2-Aminopyridine 504-29-0 99%
    2-Aminopyridine 504-29-0 99%
    504-29-0
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.